KAKadir Can Acun

Kadir Can Acun

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kadir Can Acun has a total of 359 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Lumen-Apposing Metal Stent in the Treatment of Persistent Dysphagia due to Cervical Radiation Therapy

    by Eren Yilmaz, Mucahit Ergul, Oguz Ozturk, Kadir Can Acun, Emir Tuğrul Keskin, Orhan Coskun, Ilhami Yuksel

    Cite this article as: Yilmaz E, Ergul M, Ozturk O, et al. Lumen-apposing metal stent in the treatment of persistent dysphagia due to cervical radiation therapy. Turk J Gastroenterol. Published online September 3, 2026. doi: 10.5152/tjg.2026.26290.

  • Open Access

    Lumen-Apposing Metal Stent as a Salvage Therapy for Corrosive-Induced Gastric Outlet Obstruction: A Case Report

    by Mucahit Ergul, Oguz Ozturk, Mehmet Rasit Ayte, Kadir Can Acun, Emir Tugrul Keskin, Ali Atay, Yavuz Cagir, Ilhami Yuksel

    Cite this article as: Ergul M, Ozturk O, Ayte MR, et al. Lumen-apposing metal stent as a salvage therapy for corrosive-induced gastric outlet obstruction: A case report. Turk J Gastroenterol. Published online August 18, 2026. doi: 10.5152/tjg.2026.25719

  • Open Access

    Male predominance in inflammatory bowel disease despite similar disease activity: A large retrospective cohort study

    by Ali Atay, Mucahit Ergul, Oguz Ozturk, Kadir Can Acun, Yavuz Cagir, Muhammed Bahaddin Durak, Ilhami Yuksel

    Inflammatory bowel diseases (IBD), including ulcerative colitis and Crohn’s disease (CD), exhibit clinical heterogeneity, with sex-related differences potentially influencing disease course and prognosis. This study investigates the impact of sex on IBD prognosis in a large cohort. Data were collected from patients diagnosed with IBD at our clinics between July 1993 and April 2025. Demographic, clinical, and treatment variables were analyzed, focusing on sex-based differences in disease onset, disease activity, extraintestinal manifestations (EIMs), treatment escalation, hospitalizations, and surgical interventions. A total of 1774 patients diagnosed with IBD were included in the study. A male predominance (61%) was observed in IBD, with higher male-to-female ratios in both ulcerative colitis (1.6:1) and CD (1.47:1). Female patients presented earlier with IBD (mean age 34.7 vs 37.0 years; P = .001) and had a higher frequency of EIMs, particularly peripheral arthritis and erythema nodosum ( P < .001). No significant sex differences were observed in disease severity, hospitalizations, or need for treatment escalation. However, female patients with CD demonstrated higher disease activity at baseline, as measured by the Crohn’s disease activity index. Both sexes exhibited similar rates of biologic therapy use, the number of biologic therapies, hospitalizations, and major surgeries. Despite the male predominance in IBD prevalence, sex-related differences in clinical outcomes were minimal, with both sexes experiencing comparable disease activity, treatment escalation, and need for surgery. However, female patients exhibited a higher frequency of EIMs, highlighting the importance of a sex-based approach in clinical management.


  • Open Access

    Ercp’ye Hazırlık ve Komplikasyonları

    by Orhan Coşkun, Volkan Gökbulut, Kadir Can Acun

  • Open Access

    Gastroenteroloji Textbook - Cilt (1-2)

    by Alper Macif, Ahmed Ramiz Baykan, Gökhan Çoban, Sadık Yavuz, Berk Bas, Mehmet Kasım Aydın, Selçuk Candan, Fatih Güzelbulut, Atilla Bulur, Fatih Ensaroğlu, et al.

  • Open Access

    Assessing ChatGPT-v4 for Guideline-Concordant Inflammatory Bowel Disease: Accuracy, Completeness, and Temporal Drift

    by Oguz Ozturk, Mucahit Ergul, Yavuz Cagir, Ali Atay, Kadir Can Acun, Orhan Coskun, Ilyas Tenlik, Muhammed Bahaddin Durak, Ilhami Yuksel

    Background/Objectives: Chat Generative Pretrained Transformer (ChatGPT) is a useful resource for individuals working in the healthcare field. This paper will include descriptions of several ways in which ChatGPT-4 can achieve greater accuracy in its diagnosis and treatment plans for ulcerative colitis (UC) and Crohn’s disease (CD) by following the guidelines set out by the European Crohn’s and Colitis Organization (ECCO). Methods: The survey, which comprised 102 questions, was developed to assess the precision and consistency of respondents’ responses regarding the UC and CD. The questionnaire incorporated true/false and multiple-choice questions, with the objective of simulating real-life scenarios and adhering to the ECCO guidelines. We employed Likert scales to assess the responses. The inquiries were put to ChatGPT-4 on the initial day, the 15th day, and the 180th day. Results: The 51 true or false items demonstrated stability over a six-month period, with an initial accuracy of 92.8% at baseline, 92.8% on the 15th day, and peaked to 98.0% on the 180th day. This finding suggests a negligible effect size. The accuracy of the multiple-choice questions was initially 90.2% on Day 1, reached its highest point at 92.2% on Day 15, and then decreased to 84.3% on Day 180. However, the reliability of the data was found to be suboptimal, and the impact was deemed negligible. A modest, transient increase in performance was observed at 15 days, which subsequently diminished by 180 days, resulting in negligible effect sizes. Conclusions: ChatGPT-4 demonstrates potential as a clinical decision support system for UC and CD, but its assessment is marked by temporal variability and the inconsistent execution of various tasks. Essential initiatives that should be carried out before involving artificial intelligence (AI) technology in IBD trials are routine revalidation, multi-rater comparisons, prompt standardization, and the cultivation of a comprehensive understanding of the model’s limitations.